Blog
Discover the stories and breakthroughs that continue to change cancer outcomes across British Columbia.
Introducing March guest blogger Dr. Bernie Eigl
Thank you to Dr. Marra for his riveting entries this past month. It is thrilling to hear about the global impact of Personalized …
Why we need to expand personalized cancer treatment in British Columbia
Personalized Onco-Genomics needs to grow if we’re to fully address the cancer problem here in British Columbia. Right now we have around 26,000 new cancer diagnoses …
Canadian pancreatic cancer research team provides personalized medicine, new hope to patients
VANCOUVER –Canadian pancreatic cancer researchers are joining forces under a Terry Fox initiative bringing new hope for patients with this deadly disease. “For many …
Experimental study revolutionizes cancer care across globe
The origins of POG We chart the origins of the Personalized Onco-Genomics (POG) platform to an experience that occurred around 9 years ago. We had …
Dr. Marra on cancer: “We’ve really got to get a handle on this”
Hello, my name is Dr. Marco Marra. I’m a distinguished scientist at BC Cancer, a professor of medical genetics at the University of British …
Introducing February guest blogger Dr. Marco Marra
Thank you to Dr. Connors for his insightful and informative posts this past month. It is pleasing to know that lymphoid cancer patients have some …
World Cancer Day –BC CAN move the dial on cancer
Nearly eight million people around the globe will die of cancer this year and is expected to increase to 13.2 million people per …
‘Exciting days lie ahead in lymphoid cancer research and treatment’
This week I will talk about where lymphoid cancer research is going in the future. I think the greatest promise lies in two areas. …
Game-changing discoveries made for lymphoid cancers
This week I can describe our current research focused on lymphoid cancer in British Columbia. Building on the insight we had gained in the 1980s …
BC Cancer team wins prestigious $11.9-million in project funding to develop novel tests for lymphoma patients who relapse
VANCOUVER – Today, a research team at BC Cancer will receive $11.9-million in funding for an innovative precision health project that has the potential …